A randomised, placebo-controlled, single-blind, single centre Phase I study to Assess the Safety, Tolerability and Pharmacokinetics of ascending Single Oral Dose of AZD5672 in Healthy Japanese Male Volunteers

Study identifier:D1710C00013

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, placebo-controlled, single-blind, single centre Phase I study to Assess the Safety, Tolerability and Pharmacokinetics of ascending Single Oral Dose of AZD5672 in Healthy Japanese Male Volunteers

Medical condition

Rheumatoid Arthritis

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Mar 2007
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria